Pakistan plans to secure USD 12 billion in debt rollovers from China, Saudi Arabia, and the UAE to meet budget targets before IMF talks. The country is facing a significant external financing gap.

Aster DM Healthcare plans to invest Rs 1,000 crore to expand its bed capacity in India to over 6,600 in the next three years, aiming to become a top healthcare provider.

Aster DM Healthcare reported a 29% rise in net profit to Rs 179 crore in Q3 FY24, driven by revenue growth and bed expansion. Read more.

Azad Engineering's Profit After Tax (PAT) for Q3 FY24 rose by over 300% to Rs 16.8 crore, driven by strong revenue growth and a booming aerospace and defense segment.

Industry leaders react to India's interim budget, praising focus on infrastructure, housing, healthcare, and rural development. Learn about key announcements and their impact.

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Adani Wilmar reported a consolidated net profit of Rs 313.20 crore for the April-June quarter, a significant turnaround from a loss in the same period last year.

India's government estimates its debt to rise to Rs 185 lakh crore in FY25, reaching 56.8 per cent of the GDP. The debt includes external borrowing, public account liabilities, and other liabilities.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...